Skip to main content

Advertisement

SpringerLink
Log in

Sex and Cardiovascular Involvement in Inflammatory Joint Diseases

  • Published:
Clinical Reviews in Allergy & Immunology Aims and scope Submit manuscript

Abstract

The term inflammatory joint disease (IJD) encompasses a group of chronic conditions with predominant joint involvement. They share an increased risk of cardiovascular (CV) complications. However, the implication of the sex in the risk of CV disease in IJD has not been specifically addressed. The aim of this work is to assess the influence of sex on the clinical expression of CV manifestations associated to IJD. With this objective, an update of the current knowledge of the sex influence on CV disease in patients with IJD was conducted. A PubMed database search of the most relevant literature on this topic was performed mainly based on studies published in English over the last 10 years. Although most studies on IJD were not specifically designed to address sex differences regarding CV complications, it seems that men with rheumatoid arthritis (RA) are at higher risk of pericarditis, ischemic heart disease, heart failure (HF) with reduced ejection fraction (EF), and CV mortality than women with RA. In contrast, HF with preserved EF and diastolic dysfunction is more frequent in women with RA. Men with ankylosing spondylitis present more frequently disorders of the conduction system and aortic valvulopathy than women. A limited number of studies addressed CV differences according to sex in psoriatic arthritis. Although there are some differences according to sex in the clinical expression of CV complications in patients with IJD, much research is still needed to better identify the implication of sex in the risk of CV disease in these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Castañeda S, Nurmohamed MT, González-Gay MA (2016) Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30:851–869. doi:10.1016/j.berh.2016.10.006

    Article  PubMed  Google Scholar 

  2. Agca R, Heslinga SC, van Halm VP, Nurmohamed MT (2016) Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart 102:790–795. doi:10.1136/heartjnl-2015-307838

    Article  CAS  PubMed  Google Scholar 

  3. Wolfe F, Mitchell DM, Sibley JT, Fries JF, Bloch DA, Williams CA, Spitz PW, Haga M, Kleinheksel SM, Cathey MA (1994) The mortality of rheumatoid arthritis. Arthritis Rheum 37:481–494

    Article  CAS  Google Scholar 

  4. Baeten D, Breban M, Lories R, Schett G, Sieper J (2013) Are spondylarthritides related but distinct conditions or a single disease with a heterogeneous phenotype? Arthritis Rheum 65:12–20. doi:10.1002/art.37829

    Article  PubMed  Google Scholar 

  5. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, McInnes IB, Haentzschel H, Gonzalez-Gay MA, Provan S, Semb A, Sidiropoulos P, Kitas G, Smulders YM, Soubrier M, Szekanecz Z, Sattar N, Nurmohamed MT (2010) EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis 69:325–331. doi:10.1136/ard.2009.113696

    Article  CAS  PubMed  Google Scholar 

  6. Symmons DP, Gabriel SE (2011) Epidemiology of CVD in rheumatic disease, with a focus on RA and SLE. Nat Rev Rheumatol 7:399–408. doi:10.1038/nrrheum.2011.75

    Article  PubMed  Google Scholar 

  7. Gargiulo P, Marsico F, Parente A, Paolillo S, Cecere M, Casaretti L, Pellegrino AM, Formisano T, Fabiani I, Soricelli A, Trimarco B, Perrone-Filardi P (2014) Ischemic heart disease in systemic inflammatory diseases. An appraisal. Int J Cardiol 170:286–290. doi:10.1016/j.ijcard.2013.11.048

    Article  PubMed  Google Scholar 

  8. Nurmohamed MT, Heslinga M, Kitas GD (2015) Cardiovascular comorbidity in rheumatic diseases. Nat Rev Rheumatol 11:693–704. doi:10.1038/nrrheum.2015.112

    Article  CAS  PubMed  Google Scholar 

  9. O'Sullivan M, Bruce IN, Symmons DP (2016) Cardiovascular risk and its modification in patients with connective tissue diseases. Best Pract Res Clin Rheumatol 30:81–94. doi:10.1016/j.berh.2016.03.003

    Article  PubMed  Google Scholar 

  10. Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ (2003) National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol 30:958–965

    PubMed  Google Scholar 

  11. Goodson NJ, Wiles NJ, Lunt M, Barrett EM, Silman AJ, Symmons DP (2002) Mortality in early inflammatory polyarthritis: cardiovascular mortality is increased in seropositive patients. Arthritis Rheum 46:2010–2019. doi:10.1002/art.10419

    Article  PubMed  Google Scholar 

  12. Voskuyl AE (2006) The heart and cardiovascular manifestations in rheumatoid arthritis. Rheumatology (Oxford) 45(Suppl 4):iv4–iv7. doi:10.1093/rheumatology/kel313

    Article  Google Scholar 

  13. Maradit-Kremers H, Crowson CS, Nicola PJ, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2005) Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum 52:402–411. doi:10.1002/art.20853

    Article  PubMed  Google Scholar 

  14. Maradit-Kremers H, Nicola PJ, Crowson CS, Ballman KV, Gabriel SE (2005) Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 52:722–732. doi:10.1002/art.20878

    Article  PubMed  Google Scholar 

  15. Solomon DH, Goodson NJ, Katz JN, Weinblatt ME, Avorn J, Setoguchi S, Canning C, Schneeweiss S (2006) Patterns of cardiovascular risk in rheumatoid arthritis. Ann Rheum Dis 65:1608–1612. doi:10.1136/ard.2005.050377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. Nicola PJ, Maradit-Kremers H, Roger VL, Jacobsen SJ, Crowson CS, Ballman KV, Gabriel SE (2005) The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 52:412–420. doi:10.1002/art.20855

    Article  PubMed  Google Scholar 

  17. Crowson CS, Nicola PJ, Kremers HM, O'Fallon WM, Therneau TM, Jacobsen SJ, Roger VL, Ballman KV, Gabriel SE (2005) How much of the increased incidence of heart failure in rheumatoid arthritis is attributable to traditional cardiovascular risk factors and ischemic heart disease? Arthritis Rheum 52:3039–3044. doi:10.1002/art.21349

    Article  PubMed  Google Scholar 

  18. Nicola PJ, Crowson CS, Maradit-Kremers H, Ballman KV, Roger VL, Jacobsen SJ, Gabriel SE (2006) Contribution of congestive heart failure and ischemic heart disease to excess mortality in rheumatoid arthritis. Arthritis Rheum 54:60–67. doi:10.1002/art.21560

    Article  PubMed  Google Scholar 

  19. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D (2008) Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum 59:1690–1697. doi:10.1002/art.24092

    Article  PubMed  Google Scholar 

  20. Avina-Zubieta JA, Thomas J, Sadatsafavi M, Lehman AJ, Lacaille D (2012) Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis 71:1524–1529. doi:10.1136/annrheumdis-2011-200726

    Article  PubMed  Google Scholar 

  21. Houri Levi E, Watad A, Whitby A, Tiosano S, Comaneshter D, Cohen AD, Amital H (2016) Coexistence of ischemic heart disease and rheumatoid arthritis patients—a case control study. Autoimmun Rev 15:393–396. doi:10.1016/j.autrev.2016.01.006

    Article  PubMed  Google Scholar 

  22. Castañeda S, Martín-Martínez MA, González-Juanatey C, Llorca J, García-Yébenes MJ, Pérez-Vicente S, Sánchez-Costa JT, Díaz-Gonzalez F, González-Gay MA, CARMA Project Collaborative Group (2015) Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum 44:618–626. doi:10.1016/j.semarthrit.2014.12.002

    Article  PubMed  Google Scholar 

  23. Zhang J, Chen L, Delzell E, Muntner P, Hillegass WB, Safford MM, Millan IY, Crowson CS, Curtis JR (2014) The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis 73:1301–1308. doi:10.1136/annrheumdis-2013-204715

    Article  CAS  PubMed  Google Scholar 

  24. Ambrosino P, Lupoli R, Di Minno A, Tasso M, Peluso R, Di Minno MN (2015) Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 113:916–930. doi:10.1160/TH14-11-0921

    Article  PubMed  Google Scholar 

  25. Mantel A, Holmqvist M, Andersson DC, Lund LH, Askling J (2017) Association between rheumatoid arthritis and risk of ischemic and nonischemic heart failure. J Am Coll Cardiol 69:1275–1285. doi:10.1016/j.jacc.2016.12.033

    Article  PubMed  Google Scholar 

  26. Essers I, Stolwijk C, Boonen A, De Bruin ML, Bazelier MT, de Vries F, van Tubergen A (2016) Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study. Ann Rheum Dis 75:203–209. doi:10.1136/annrheumdis-2014-206147

    Article  PubMed  Google Scholar 

  27. Horreau C, Pouplard C, Brenaut E, Barnetche T, Misery L, Cribier B, Jullien D, Aractingi S, Aubin F, Joly P, Le Maître M, Ortonne JP, Paul C, Richard MA (2013) Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review. J Eur Acad Dermatol Venereol 27(Suppl 3):12–29. doi:10.1111/jdv.12163

    Article  PubMed  Google Scholar 

  28. Hara KS, Ballard DJ, Ilstrup DM, Connolly DC, Vollertsen RS (1990) Rheumatoid pericarditis: clinical features and survival. Medicine (Baltimore) 69:81–91

    Article  CAS  Google Scholar 

  29. Pappas DA, Taube JM, Bathon JM, Giles JT (2008) A 73-year-old woman with rheumatoid arthritis and shortness of breath. Arthritis Rheum 59:892–899. doi:10.1002/art.23720

    Article  PubMed  Google Scholar 

  30. Guedes C, Bianchi-Fior P, Cormier B, Barthelemy B, Rat AC, Boissier AC (2001) Cardiac manifestations of rheumatoid arthritis: a case–control transesophageal echocardiography study in 30 patients. Arthritis Rheum 45:129–135. doi:10.1002/1529-0131(200104)45:2<129::AID-ANR164>3.0.CO;2-K

    Article  CAS  PubMed  Google Scholar 

  31. Roldan CA, Chavez J, Weist P, Qualls CR, Crawford MH (1998) Aortic root disease and valve disease associated with ankylosing spondylitis. J Am Coll Cardiol 32:1397–1404

    Article  CAS  Google Scholar 

  32. Hopper I, Kotecha D, Chin KL, Mentz RJ, von Lueder TG (2016) Comorbidities in heart failure: are there gender differences? Curr Heart Fail Rep 13:1–12. doi:10.1007/s11897-016-0280-1

    Article  PubMed  Google Scholar 

  33. Gonzalez A, Maradit Kremers H, Crowson CS, Nicola PJ, Davis JM 3rd, Therneau TM, Roger VL, Gabriel SE (2007) The widening mortality gap between rheumatoid arthritis patients and the general population. Arthritis Rheum 56:3583–3587. doi:10.1002/art.22979

    Article  PubMed  Google Scholar 

  34. Myasoedova E, Crowson CS, Nicola PJ, Maradit-Kremers H, Davis JM 3rd, Roger VL, Therneau TM, Gabriel SE (2011) The influence of rheumatoid arthritis disease characteristics in heart failure. J Rheumatol 38:1601–1606. doi:10.3899/jrheum.100979

    Article  PubMed  PubMed Central  Google Scholar 

  35. Heslinga SC, Van Dongen CJ, Konings TC, Peters MJ, Van der Horst-Bruinsma IE, Smulders YM, Nurmohamed MT (2014) Diastolic left ventricular dysfunction in ankylosing spondylitis—a systematic review and meta-analysis. Semin Arthritis Rheum 44:14–19. doi:10.1016/j.semarthrit.2014.02.004

    Article  PubMed  Google Scholar 

  36. Chen Y, Chung HY, Zhao CT, Wong A, Zhen Z, Tsang HH, Lau CS, Tse HF, Yiu KH (2015) Left ventricular myocardial dysfunction and premature atherosclerosis in patients with axial spondyloarthritis. Rheumatology (Oxford) 54:292–301. doi:10.1093/rheumatology/keu337

    Article  CAS  Google Scholar 

  37. Nyrnes A, Njølstad I, Mathiesen E, Wilsgaard T, Hansen JB, Skjelbakken T, Jørgensen L, Løchen ML (2012) Inflammatory biomarkers as risk factors for future atrial fibrillation. An eleven-year follow-up of 6315 men and women: The Tromsø study. Gend Med 9:536–547.e2. doi:10.1016/j.genm.2012.09.001

    Article  PubMed  Google Scholar 

  38. Panoulas VF, Toms TE, Douglas KM, Sandoo A, Metsios GS, Stavropoulos-Kalinoglou A, Kitas GD (2014) Prolonged QTc interval predicts all-cause mortality in patients with rheumatoid arthritis: an association driven by high inflammatory burden. Rheumatology (Oxford) 53:131–137. doi:10.1093/rheumatology/ket338

    Article  Google Scholar 

  39. Forsblad-d’Elia H, Wallberg H, Klingberg E, Carlsten H, Bergfeldt L (2013) Cardiac conduction system abnormalities in ankylosing spondylitis: a cross-sectional study. BMC Musculoskelet Disord 14:237. doi:10.1186/1471-2474-14-237

    Article  PubMed  PubMed Central  Google Scholar 

  40. Gensler LS (2015) Axial spondyloarthritis: the heart of the matter. Clin Rheumatol 34:995–998. doi:10.1007/s10067-015-2959-1

    Article  PubMed  Google Scholar 

  41. Chiu HY, Chang WL, Huang WF, Wen YW, Tsai YW, Tsai TF (2015) Increased risk of arrhythmia in patients with psoriatic disease: a nationwide population-based matched cohort study. J Am Acad Dermatol 73:429–438. doi:10.1016/j.jaad.2015.06.023

    Article  PubMed  Google Scholar 

  42. Holmqvist M, Neovius M, Eriksson J, Mantel A, Wallberg- Jonsson S, Jacobsson LT, Askling J (2012) Risk of venous thromboembolism in patients with rheumatoid arthritis and association with disease duration and hospitalization. JAMA 308:1350–1356. doi:10.1001/2012.jama.11741

    Article  CAS  PubMed  Google Scholar 

  43. Eriksson JK, Jacobsson L, Bengtsson K, Askling J (2017) Is ankylosing spondylitis a risk factor for cardiovascular disease, and how do these risks compare with those in rheumatoid arthritis? Ann Rheum Dis 76:364–370. doi:10.1136/annrheumdis-2016-209315

    Article  PubMed  Google Scholar 

  44. Gabriel SE, Crowson CS, O’Fallon WM (1999) Comorbidity in arthritis. J Rheumatol 26:2475–2479

    CAS  PubMed  Google Scholar 

  45. Wolfe F, Freundlich B, Straus WL (2003) Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol 30:36–40

    PubMed  Google Scholar 

  46. Han C, Robinson DW Jr, Hackett MV, Paramore LC, Fraeman KH, Bala MV (2006) Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 33:2167–2172

    PubMed  Google Scholar 

  47. Szabo SM, Levy AR, Rao SR, Kirbach SE, Lacaille D, Cifaldi M, Maksymowych WP (2011) Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study. Arthritis Rheum 63:3294–3304. doi:10.1002/art.30581

    Article  PubMed  Google Scholar 

  48. Mathieu S, Pereira B, Soubrier M (2015) Cardiovascular events in ankylosing spondylitis: an updated meta-analysis. Semin Arthritis Rheum 44:551–555. doi:10.1016/j.semarthrit.2014.10.007

    Article  PubMed  Google Scholar 

  49. Daudén E, Castañeda S, Suárez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo J, Grupo de Trabajo en Comorbilidades asociadas a la Psoriasis (2012) Integrated approach to comorbidity in patients with psoriasis.Working Group on Psoriasis-associated Comorbidities. Actas Dermosifiliogr 103(Suppl 1):1–64. doi:10.1016/S0001-7310(12)70001-7

    Article  PubMed  Google Scholar 

  50. Dauden E, Castañeda S, Suarez C, García-Campayo J, Blasco AJ, Aguilar MD, Ferrándiz C, Puig L, Sánchez-Carazo JL, Working Group on Comorbidity in Psoriasis (2013) Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol 27:1387–1404. doi:10.1111/jdv.12024

    Article  Google Scholar 

  51. Gladman DD, Ang M, Su L, Schentag CT, Farewell VT (2009) Cardiovascular morbidity in psoriatic arthritis. Ann Rheum Dis 68:1131–1135. doi:10.1136/ard.2008.094839

    Article  CAS  PubMed  Google Scholar 

  52. Wong K, Gladman DD, Husted J, Long JA, Farewell VT (1997) Mortality studies in psoriatic arthritis: results from a single outpatient clinic. I. Causes and risk of death. Arthritis Rheum 40:1868–1872. doi:10.1002/1529–0131(199710)40:10&lt;1868::AID-ART21&gt;3.0.CO;2-W

    Article  CAS  PubMed  Google Scholar 

  53. Ernste FC, Sanchez-Menendez M, Wilton KM, Crowson CS, Matteson EL, Maradit Kremers H (2015) Cardiovascular risk profile at the onset of psoriatic arthritis: a population-based cohort study. Arthritis Care Res (Hoboken) 67:1015–1021. doi:10.1002/acr.22536

    Article  CAS  Google Scholar 

  54. Liao KP, Solomon DH (2013) Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford) 52:45–52. doi:10.1093/rheumatology/kes243

    Article  Google Scholar 

  55. Sen D, González-Mayda M, Brasington RD Jr (2014) Cardiovascular disease in rheumatoid arthritis. Rheum Dis Clin N Am 40:27–49. doi:10.1016/j.rdc.2013.10.005

    Article  Google Scholar 

  56. Giles JT (2015) Cardiovascular disease in rheumatoid arthritis: current perspectives on assessing and mitigating risk in clinical practice. Best Pract Res Clin Rheumatol 29:597–613. doi:10.1016/j.berh.2015.09.003

    Article  PubMed  Google Scholar 

  57. Crowson CS, Therneau TM, Davis JM 3rd, Roger VL, Matteson EL, Gabriel SE (2013) Accelerated aging influences cardiovascular disease risk in rheumatoid arthritis. Arthritis Rheum 65:2562–2566. doi:10.1002/art.38071

    Article  PubMed  PubMed Central  Google Scholar 

  58. Bergstrom U, Jacobsson LT, Nilsson JA, Berglund G, Turesson C (2011) Pulmonary dysfunction, smoking, socioeconomic status and the risk of developing rheumatoid arthritis. Rheumatology (Oxford) 50:2005–2013. doi:10.1093/rheumatology/ker258

    Article  Google Scholar 

  59. Boyer JF, Gourraud PA, Cantagrel A, Davignon JL, Constantin A (2011) Traditional cardiovascular risk factors in rheumatoid arthritis: a meta-analysis. Joint Bone Spine 78:179–183. doi:10.1016/j.jbspin.2010.07.016

    Article  PubMed  Google Scholar 

  60. Jamnitski A, Symmons D, Peters MJ, Sattar N, McInnes I, Nurmohamed MT (2013) Cardiovascular comorbidities in patients with psoriatic arthritis: a systematic review. Ann Rheum Dis 72:211–216. doi:10.1136/annrheumdis-2011-201194

    Article  PubMed  Google Scholar 

  61. Zhang J, Fu L, Shi J, Chen X, Li Y, Ma B, Zhang Y (2013) The risk of metabolic syndrome in patients with rheumatoid arthritis: a meta-analysis of observational studies. PLoS One 8:e78151. doi:10.1371/journal.pone.0078151

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  62. Ferraz-Amaro I, González-Juanatey C, López-Mejias R, Riancho-Zarrabeitia L, González-Gay MA (2013) Metabolic syndrome in rheumatoid arthritis. Mediat Inflamm 2013:710928. doi:10.1155/2013/710928

    Article  CAS  Google Scholar 

  63. Giles JT, Allison M, Blumenthal RS, Post W, Gelber AC, Petri M, Tracy R, Szklo M, Bathon JM (2010) Abdominal adiposity in rheumatoid arthritis: association with cardiometabolic risk factors and disease characteristics. Arthritis Rheum 62:3173–3182. doi:10.1002/art.27629

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  64. Panoulas VF, Douglas KM, Milionis HJ, Stavropoulos-Kalinglou A, Nightingale P, Kita MD, Tselios AL, Metsios GS, Elisaf MS, Kitas GD (2007) Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology (Oxford) 46:1477–1482. doi:10.1093/rheumatology/kem169

    Article  CAS  Google Scholar 

  65. Popa CD, Arts E, Fransen J, van Riel PL (2012) Atherogenic index and high-density lipoprotein cholesterol as cardiovascular risk determinants in rheumatoid arthritis: the impact of therapy with biologicals. Mediat Inflamm 2012:785946. doi:10.1155/2012/785946

    Article  CAS  Google Scholar 

  66. Myasoedova E, Crowson CS, Kremers HM, Fitz-Gibbon PD, Therneau TM, Gabriel SE (2010) Total cholesterol and LDL levels decrease before rheumatoid arthritis. Ann Rheum Dis 69:1310–1314. doi:10.1136/ard.2009.122374

    Article  CAS  PubMed  Google Scholar 

  67. Mathieu S, Motreff P, Soubrier M (2010) Spondyloarthropathies: an independent cardiovascular risk factor? Joint Bone Spine 77:542–545. doi:10.1016/j.jbspin.2010.05.001

    Article  PubMed  Google Scholar 

  68. John H, Kitas G (2012) Inflammatory arthritis as a novel risk factor for cardiovascular disease. Eur J Intern Med 23:575–579. doi:10.1016/j.ejim.2012.06.016

    Article  PubMed  Google Scholar 

  69. van Halm VP, van Denderen JC, Peters MJ, Twisk JW, van der Paardt M, van der Horst-Bruinsma IE, van de Stadt RJ, de Koning MH, Dijkmans BA, Nurmohamed MT (2006) Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis. Ann Rheum Dis 65:1473–1477. doi:10.1136/ard.2005.050443

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. van Eijk IC, de Vries MK, Levels JH, Peters MJ, Huizer EE, Dijkmans BA, van der Horst-Bruinsma IE, Hazenberg BP, van de Stadt RJ, Wolbink GJ, Nurmohamed MT (2009) Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: a prospective cohort study in ankylosing spondylitis. Arthritis Rheum 60:1324–1330. doi:10.1002/art.24492

    Article  PubMed  Google Scholar 

  71. Gonzalez-Gay MA, Gonzalez-Juanatey C, Piñeiro A, Garcia-Porrúa C, Testa A, Llorca J (2005) High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis. J Rheumatol 32:1219–1223

    CAS  PubMed  Google Scholar 

  72. Gonzalez-Gay MA, Gonzalez-Juanatey C, Lopez-Diaz MJ, Piñeiro A, Garcia-Porrua C, Miranda-Filloy JA, Ollier WE, Martin J, Llorca J (2007) HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis. Arthritis Rheum 57:125–132. doi:10.1002/art.22482

    Article  CAS  PubMed  Google Scholar 

  73. Gonzalez-Gay MA, Gonzalez-Juanatey C, Martin J (2005) Rheumatoid arthritis: a disease associated with accelerated atherogenesis. Semin Arthritis Rheum 35:8–17. doi:10.1016/j.semarthrit.2005.03.004

    Article  PubMed  Google Scholar 

  74. Libby P, Crea F (2010) Clinical implications of inflammation for cardiovascular primary prevention. Eur Heart J 31:777–783. doi:10.1093/eurheartj/ehq022

    Article  CAS  PubMed  Google Scholar 

  75. Hollan I, Meroni PL, Ahearn JM, Cohen Tervaert JW, Curran S, Goodyear CS, Hestad KA, Kahaleh B, Riggio M, Shields K, Wasko MC (2013) Cardiovascular disease in autoimmune rheumatic diseases. Autoimmun Rev 12:1004–1015. doi:10.1016/j.autrev.2013.03.013

    Article  CAS  PubMed  Google Scholar 

  76. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Vidan J, Hajeer AH, Ollier WE, Mattey DL, Gonzalez-Gay MA (2003) HLA-DRB1 status affects endothelial function in treated patients with rheumatoid arthritis. Am J Med 114:647–652

    Article  CAS  Google Scholar 

  77. Gonzalez-Juanatey C, Llorca J, Miranda-Filloy JA, Amigo-Diaz E, Testa A, Garcia-Porrua C, Martin J, Gonzalez-Gay MA (2007) Endothelial dysfunction in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Arthritis Rheum 57:287–293. doi:10.1002/art.22530

    Article  CAS  PubMed  Google Scholar 

  78. Bodnár N, Kerekes G, Seres I, Paragh G, Kappelmayer J, Némethné ZG, Szegedi G, Shoenfeld Y, Sipka S, Soltész P, Szekanecz Z, Szántó S (2011) Assessment of subclinical vascular disease associated with ankylosing spondylitis. J Rheumatol 38:723–729. doi:10.3899/jrheum.100668

    Article  PubMed  Google Scholar 

  79. López-Mejías R, Castañeda S, González-Juanatey C, Corrales A, Ferraz-Amaro I, Genre F, Remuzgo-Martínez S, Rodriguez-Rodriguez L, Blanco R, Llorca J, Martín J, González-Gay MA (2016) Cardiovascular risk assessment in patients with rheumatoid arthritis: the relevance of clinical, genetic and serological markers. Autoimmun Rev 15:1013–1030. doi:10.1016/j.autrev.2016.07.026

    Article  PubMed  Google Scholar 

  80. Gonzalez-Juanatey C, Llorca J, Testa A, Revuelta J, Garcia-Porrua C, Gonzalez-Gay MA (2003) Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease. Medicine (Baltimore) 82:407–413. doi:10.1097/01.md.0000101572.76273.60

    Article  Google Scholar 

  81. Gonzalez-Juanatey C, Llorca J, Amigo-Diaz E, Dierssen T, Martin J, Gonzalez-Gay MA (2007) High prevalence of subclinical atherosclerosis in PsA patients without clinically evident CVD or classic atherosclerosis risk factors. Arthritis Rheum 57:1074–1080. doi:10.1002/art.22884

    Article  PubMed  Google Scholar 

  82. Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Miranda-Filloy JA, Dierssen T, Vaqueiro I, Blanco R, Martin J, Llorca J, Gonzalez-Gay MA (2009) The high prevalence of subclinical atherosclerosis in patients with ankylosing spondylitis without clinically evident cardiovascular disease. Medicine (Baltimore) 88:358–365. doi:10.1097/MD.0b013e3181c10773

    Article  Google Scholar 

  83. Corrales A, González-Juanatey C, Peiró ME, Blanco R, Llorca J, González-Gay MA (2014) Carotid ultrasound is useful for the cardiovascular risk stratification of patients with rheumatoid arthritis: results of a population-based study. Ann Rheum Dis 73:722–727. doi:10.1136/annrheumdis-2012-203101

    Article  PubMed  Google Scholar 

  84. Corrales A, Parra JA, González-Juanatey C, Rueda-Gotor J, Blanco R, Llorca J, González-Gay MA (2013) Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 72:1764–1770. doi:10.1136/annrheumdis-2013-203688

    Article  CAS  PubMed  Google Scholar 

  85. Rueda-Gotor J, Llorca J, Corrales A, Blanco R, Fuentevilla P, Portilla V, Expósito R, Mata C, Pina T, González-Juanatey C, González-Gay MA (2016) Carotid ultrasound in the cardiovascular risk stratification of patients with ankylosing spondylitis: results of a population-based study. Clin Exp Rheumatol 34:885–892

    PubMed  Google Scholar 

  86. Hollan I, Prayson R, Saatvedt K, Almdahl SM, Nossent HC, Mikkelsen K, Liang MH, Kvelstad IL, Aamodt G, Førre OT (2008) Inflammatory cell infiltrates in vessels with different susceptibility to atherosclerosis in rheumatic and non-rheumatic patients. Circ J 72:1986–1992

    Article  Google Scholar 

  87. Kitas GD, Banks M, Bacon PA (2001) Cardiac involvement in rheumatoid disease. Clin Med (Lond) 1:18–21

    Article  CAS  Google Scholar 

  88. Hurd ER (1979) Extraarticular manifestations of rheumatoid arthritis. Semin Arthritis Rheum 8:151–176

    Article  CAS  Google Scholar 

  89. Jurik AG, Graudal H (1986) Pericarditis in rheumatoid arthritis. A clinical and radiological study. Rheumatol Int 6:37–42

    Article  CAS  Google Scholar 

  90. Escalante A, Kaufman RL, Quismorio FP Jr, Beardmore TD (1990) Cardiac compression in rheumatoid pericarditis. Semin Arthritis Rheum 20:148–163

    Article  CAS  Google Scholar 

  91. Gonzalez-Juanatey C, Testa A, Garcia-Castelo A, Garcia-Porrua C, Llorca J, Ollier WE, Gonzalez-Gay MA (2004) Echocardiographic and Doppler findings in long-term treated rheumatoid arthritis patients without clinically evident cardiovascular disease. Semin Arthritis Rheum 33:231–238

    Article  Google Scholar 

  92. Roldan CA (2008) Valvular and coronary heart disease in systemic inflammatory diseases: systemic disorders in heart disease. Heart 94:1089–1101. doi:10.1136/hrt.2007.132787

    Article  PubMed  Google Scholar 

  93. Kang H, Baron M (2004) Embolic complications of a mitral valve rheumatoid nodule. J Rheumatol 31:1001–1003

    PubMed  Google Scholar 

  94. Gonzalez-Juanatey C, Amigo-Diaz E, Miranda-Filloy JA, Testa A, Revuelta J, Garcia-Porrua C, Martin J, Llorca J, Gonzalez-Gay MA (2006) Lack of echocardiographic and Doppler abnormalities in psoriatic arthritis patients without clinically evident cardiovascular disease or classic atherosclerosis risk factors. Semin Arthritis Rheum 35:333–339. doi:10.1016/j.semarthrit.2005.12.002

    Article  PubMed  Google Scholar 

  95. Ouzounian M, Lee DS, Liu PP (2008) Diastolic heart failure: mechanisms and controversies. Nat Clin Pract Cardiovasc Med 5:375–386. doi:10.1038/ncpcardio1245

    Article  PubMed  Google Scholar 

  96. Weber KT, Brilla CG (1991) Pathological hypertrophy and cardiac interstitium: fibrosis and renin-angiotensin-aldosterone system. Circulation 83:1849–1865

    Article  CAS  Google Scholar 

  97. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, González-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors/Task Force Members (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: The task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37:2129–2200. doi:10.1093/eurheartj/ehw128

    Article  Google Scholar 

  98. Paulus WJ, Tschöpe C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE, Marino P, Smiseth OA, De Keulenaer G, Leite-Moreira AF, Borbély A, Edes I, Handoko ML, Heymans S, Pezzali N, Pieske B, Dickstein K, Fraser AG, Brutsaert DL (2007) How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28:2539–2550. doi:10.1093/eurheartj/ehm037

    Article  PubMed  Google Scholar 

  99. Paulus WJ, Tschöpe C (2013) A novel paradigm for heart failure with preserved ejection fraction: Comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol 62:263–271. doi:10.1016/j.jacc.2013.02.092

    Article  Google Scholar 

  100. Zile MR, Brutsaert DL (2002) New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment. Circulation 105:1503–1508

    Article  Google Scholar 

  101. Fukuta H, Little WC (2007) Diagnosis of diastolic heart failure. Curr Cardiol Rep 9:224–228

    Article  Google Scholar 

  102. Redfield MM, Jacobsen SJ, Burnett JC Jr, Mahoney DW, Bailey KR, Rodeheffer RJ (2003) Burden of systolic and diastolic ventricular dysfunction in the community: appreciating the scope of the heart failure epidemic. JAMA 289:194–202

    Article  Google Scholar 

  103. Halley CM, Houghtaling PL, Khalil MK, Thomas JD, Jaber WA (2011) Mortality rate in patients with diastolic dysfunction and normal systolic function. Arch Intern Med 171:1082–1087. doi:10.1001/archinternmed.2011.244

    Article  PubMed  Google Scholar 

  104. Achong N, Wahi S, Marwick TH (2009) Evolution and outcome of diastolic dysfunction. Heart 95:813–818. doi:10.1136/hrt.2008.159020

    Article  CAS  PubMed  Google Scholar 

  105. Aslam F, Bandeali SJ, Khan NA, Alam M (2013) Diastolic dysfunction in rheumatoid arthritis: a meta-analysis and systematic review. Arthritis Care Res (Hoboken) 65:534–543. doi:10.1002/acr.21861

    Article  Google Scholar 

  106. Kane GC, Karon BL, Mahoney DW, Redfield MM, Roger VL, Burnett JC Jr, Jacobsen SJ, Rodeheffer RJ (2011) Progression of left ventricular diastolic dysfunction and risk of heart failure. JAMA 306:856–863. doi:10.1001/jama.2011.1201

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Mentz RJ, Felker GM (2013) Noncardiac comorbidities and acute heart failure patients. Heart Fail Clin 9:359–367. doi:10.1016/j.hfc.2013.04.003

    Article  PubMed  PubMed Central  Google Scholar 

  108. Yancy CW, Lopatin M, Stevenson LW, De Marco T, Fonarow GC, ADHERE Scientific Advisory Committee and Investigators (2006) Clinical presentation, management, and in-hospital outcomes of patients admitted with acute decompensated heart failure with preserved systolic function: a report from the acute decompensated heart failure National Registry (ADHERE) database. J Am Coll Cardiol 47:76–84. doi:10.1016/j.jacc.2005.09.022

    Article  PubMed  Google Scholar 

  109. Centers for Medicare & Medicaid Services (2012) Chronic conditions among Medicare Beneficiaries. Chartbook, 2012th edn. Centers for Medicare & Medicaid Services, Baltimore

  110. van Deursen VM, Urso R, Laroche C, Damman K, Dahlström U, Tavazzi L, Maggioni AP, Voors AA (2014) Comorbidities in patients with heart failure: an analysis of the European Heart Failure Pilot Survey. Eur J Heart Fail 16:103–111. doi:10.1002/ejhf.30

    Article  PubMed  Google Scholar 

  111. He J, Ogden LG, Bazzano LA, Vupputuri S, Loria C, Whelton PK (2001) Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 161:996–1002

    Article  CAS  Google Scholar 

  112. Wolfe F, Michaud K (2004) Heart failure in rheumatoid arthritis: rates, predictors, and the effect of anti-tumor necrosis factor therapy. Am J Med 116:305–311. doi:10.1016/j.amjmed.2003.09.039

    Article  PubMed  Google Scholar 

  113. Mutru O, Laakso M, Isomäki H, Koota K (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology 76:71–77

    Article  CAS  Google Scholar 

  114. Giles JT, Fernandes V, Lima JA, Bathon JM (2005) Myocardial dysfunction in rheumatoid arthritis: epidemiology and pathogenesis. Arthritis Res Ther 7:195–207. doi:10.1186/ar1814

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  115. Crowson CS, Myasoedova E, Davis JM 3rd, Roger VL, Karon BL, Borgeson D, Rodeheffer RJ, Therneau TM, Gabriel SE (2011) Use of B-type natriuretic peptide as a screening tool for left ventricular diastolic dysfunction in rheumatoid arthritis patients without clinical cardiovascular disease. Arthritis Care Res (Hoboken) 63:729–734. doi:10.1002/acr.20425

    Article  CAS  Google Scholar 

  116. Sveälv BG, Täng MS, Klingberg E, Forsblad-d'Elia H, Bergfeldt L (2015) Prevalence of diastolic dysfunction in patients with ankylosing spondylitis: a cross-sectional study. Scand J Rheumatol 44:111–117. doi:10.3109/03009742.2014.953201

    Article  PubMed  Google Scholar 

  117. Shang Q, Tam LS, Yip GW, Sanderson JE, Zhang Q, Li EK, Yu CM (2011) High prevalence of subclinical left ventricular dysfunction in patients with psoriatic arthritis. J Rheumatol 38:1363–1370. doi:10.3899/jrheum.101136

    Article  PubMed  Google Scholar 

  118. Shang Q, Tam LS, Sanderson JE, Sun JP, Li EK, Yu CM (2012) Increase in ventricular-arterial stiffness in patients with psoriatic arthritis. Rheumatology (Oxford) 51:2215–2223. doi:10.1093/rheumatology/kes213

    Article  Google Scholar 

  119. Bergner DW, Goldberger JJ (2010) Diabetes mellitus and sudden cardiac death: what are the data? Cardiol J 17:117–129

    PubMed  Google Scholar 

  120. Lazzerini PE, Capecchi PL, Acampa M, Galeazzi M, Laghi-Pasini F (2014) Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. Autoimmun Rev 13:936–944. doi:10.1016/j.autrev.2014.05.007

    Article  PubMed  Google Scholar 

  121. London B, Baker LC, Lee JS, Shusterman V, Choi BR, Kubota T, McTiernan CF, Feldman AM, Salama G (2003) Calcium-dependent arrhythmias in transgenic mice with heart failure. Am J Physiol Heart Circ Physiol 284:H431–H441. doi:10.1152/ajpheart.00431.2002

    Article  CAS  PubMed  Google Scholar 

  122. Petkova-Kirova PS, Gursoy E, Mehdi H, McTiernan CF, London B, Salama G (2006) Electrical remodeling of cardiacmyocytes from mice with heart failure due to the overexpression of tumor necrosis factor-alpha. Am J Physiol Heart Circ Physiol 290:H2098–H2107. doi:10.1152/ajpheart.00097.2005

    Article  CAS  PubMed  Google Scholar 

  123. Goldstein LB, Bushnell CD, Adams RJ, Appel LJ, Braun LT, Chaturvedi S, Creager MA, Culebras A, Eckel RH, Hart RG, Hinchey JA, Howard VJ, Jauch EC, Levine SR, Meschia JF, Moore WS, Nixon JV, Pearson TA, American Heart Association Stroke Council; Council on Cardiovascular Nursing; Council on Epidemiology and Prevention; Council for High Blood Pressure Research,; Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research (2011) Guidelines for the primary prevention of stroke: A guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 42:517–584. doi:10.1161/STR.0b013e3181fcb238

    Article  PubMed  Google Scholar 

  124. Friedrichs K, Klinke A, Baldus S (2011) Inflammatory pathways underlying atrial fibrillation. Trends Mol Med 17:556–563. doi:10.1016/j.molmed.2011.05.007

    Article  CAS  PubMed  Google Scholar 

  125. Lindhardsen J, Ahlehoff O, Gislason GH, Madsen OR, Olesen JB, Svendsen JH, Torp-Pedersen C, Hansen PR (2012) Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study. BMJ 344:e1257. doi:10.1136/bmj.e1257

    Article  PubMed  PubMed Central  Google Scholar 

  126. Engelmann MD, Svendsen JH (2005) Inflammation in the genesis and perpetuation of atrial fibrillation. Eur Heart J 26:2083–2092. doi:10.1093/eurheartj/ehi350

    Article  CAS  PubMed  Google Scholar 

  127. Liu T, Li G, Li L, Korantzopoulos P (2007) Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49:1642–1648. doi:10.1016/j.jacc.2006.12.042

    Article  CAS  PubMed  Google Scholar 

  128. Dilaveris PE, Gialafos JE (2001) P-wave dispersion: a novel predictor of paroxysmal atrial fibrillation. Ann Noninvasive Electrocardiol 6:159–165

    Article  CAS  Google Scholar 

  129. Yavuzkir M, Ozturk A, Dagli N, Koca S, Karaca I, Balin M, Işik A (2007) Effect of ongoing inflammation in rheumatoid arthritis on P-wave dispersion. J Int Med Res 35:796–802. doi:10.1177/147323000703500608

    Article  CAS  PubMed  Google Scholar 

  130. Guler H, Seyfeli E, Sahin G, Duru M, Akgul F, Saglam H, Yalcin F (2007) P wave dispersion in patients with rheumatoid arthritis: its relation with clinical and echocardiographic parameters. Rheumatol Int 27:813–818. doi:10.1007/s00296-007-0307-8

    Article  PubMed  Google Scholar 

  131. Dik VK, Peters MJ, Dijkmans PA, Van der Weijden MA, De Vries MK, Dijkmans BA, Van der Horst-Bruinsma IE, Nurmohamed MT (2010) The relationship between disease-related characteristics and conduction disturbances in ankylosing spondylitis. Scand J Rheumatol 39:38–41. doi:10.3109/03009740903096101

    Article  CAS  PubMed  Google Scholar 

  132. Shoenfeld Y, Gerli R, Doria A, Matsuura E, Cerinic MM, Ronda N, Jara LJ, Abu-Shakra M, Meroni PL, Sherer Y (2005) Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation 112:3337–3347. doi:10.1161/CIRCULATIONAHA.104.507996

    Article  PubMed  Google Scholar 

  133. Bisoendial RJ, Levi M, Tak PP, Stroes ES (2010) The prothrombotic state in rheumatoid arthritis: an additive risk factor for adverse cardiovascular events. Semin Thromb Hemost 36:452–457. doi:10.1055/s-0030-1254054

    Article  CAS  PubMed  Google Scholar 

  134. Full LE, Monaco C (2011) Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis. Cardiovasc Ther 29:231–242. doi:10.1111/j.1755-5922.2010.00159.x

    Article  CAS  PubMed  Google Scholar 

  135. Bacani AK, Gabriel SE, Crowson CS, Heit JA, Matteson EL (2012) Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events? Arthritis Rheum 64:53–61. doi:10.1002/art.33322

    Article  PubMed  PubMed Central  Google Scholar 

  136. Matta F, Singala R, Yaekoub A, Najjar R, Stein PD (2009) Risk of venous thromboembolism with rheumatoid arthritis. Thromb Haemost 101:134–138

    Article  CAS  Google Scholar 

  137. Ramagopalan SV, Wotton CJ, Handel AE, Yeates D, Goldacre MJ (2011) Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med 9:1. doi:10.1186/1741-7015-9-1

    Article  PubMed  PubMed Central  Google Scholar 

  138. Johannesdottir SA, Schmidt M, Horvath-Puho E, Sorensen HT (2012) Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case control study. J Thromb Haemost 10:815–821. doi:10.1111/j.1538-7836.2012.04666.x

    Article  CAS  PubMed  Google Scholar 

  139. Zoller B, Li X, Sundquist J, Sundquist K (2012) Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden. Lancet 379(9812):244–249. doi:10.1016/S0140-6736(11)61306-8

    Article  PubMed  Google Scholar 

  140. Choi HK, Rho YH, Zhu Y, Cea-Soriano L, Avina-Zubieta JA, Zhang Y (2013) The risk of pulmonary embolism and deep vein thrombosis in rheumatoid arthritis: a UK population-based outpatient cohort study. Ann Rheum Dis 72:1182–1187. doi:10.1136/annrheumdis-2012-201669

    Article  PubMed  Google Scholar 

  141. Ungprasert P, Sanguankeo A, Upala S, Suksaranjit P (2014) Psoriasis and risk of venous thromboembolism: a systematic review and meta-analysis. QJM 107:793–797. doi:10.1093/qjmed/hcu073

    Article  CAS  PubMed  Google Scholar 

  142. Chung WS, Peng CL, Lin CL, Chang YJ, Chen YF, Chiang JY, Sung FC, Kao CH (2014) Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study. Ann Rheum Dis 73:1774–1780. doi:10.1136/annrheumdis-2013-203380

    Article  PubMed  Google Scholar 

  143. Adams KF Jr, Dunlap SH, Sueta CA, Clarke SW, Patterson JH, Blauwet MB, Jensen LR, Tomasko L, Koch G (1996) Relation between gender, etiology and survival in patients with symptomatic heart failure. J Am Coll Cardiol 28:1781–1788. doi:10.1016/S0735-1097(96)00380-4

    Article  PubMed  Google Scholar 

  144. Alla F, Al-Hindi AY, Lee CR, Schwartz TA, Patterson JH, Adams KF Jr (2007) Relation of sex to morbidity and mortality in patients with heart failure and reduced or preserved left ventricular ejection fraction. Am Heart J 153:1074–1080. doi:10.1016/j.ahj.2007.03.016

    Article  PubMed  Google Scholar 

  145. Tasevska-Dinevska G, Kennedy LM, Nilsson PM, Willenheimer R (2009) Gender aspects on heart failure incidence and mortality in a middle-aged, urban, community-based population sample: the Malmo preventive project. Eur J Epidemiol 24:249–257. doi:10.1007/s10654-009-9320-4

    Article  CAS  PubMed  Google Scholar 

  146. Conde-Martel A, Arkuch ME, Formiga F, Manzano-Espinosa L, Aramburu-Bodas O, Gonzalez-Franco A, Davila-Ramos MF, Suarez-Pedreira I, Herrero-Domingo A, Montero-Perez-Barquero M (2015) Gender related differences in clinical profile and outcome of patients with heart failure. Results of the RICA Registry. Rev Clin Esp 215:363–370. doi:10.1016/j.rce.2015.02.010

    Article  CAS  PubMed  Google Scholar 

  147. Fonarow GC, Abraham WT, Albert NM, Stough WG, Gheorghiade M, Greenberg BH, O'Connor CM, Sun JL, Yancy C, Young JB, OPTIMIZE-HF Investigators and Hospitals (2009) Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF). Am J Cardiol 104:107–115. doi:10.1016/j.amjcard.2009.02.057

    Article  PubMed  Google Scholar 

  148. Ghali JK, Krause-Steinrauf HJ, Adams KF, Khan SS, Rosenberg YD, Yancy CW, Young JB, Goldman S, Peberdy MA, Lindenfeld J (2003) Gender differences in advanced heart failure: insights from the BEST study. J Am Coll Cardiol 42:2128–2134

    Article  Google Scholar 

  149. Nieminen MS, Harjola VP, Hochadel M, Drexler H, Komajda M, Brutsaert D, Dickstein K, Ponikowski P, Tavazzi L, Follath F, Lopez-Sendon JL (2008) Gender related differences in patients presenting with acute heart failure. Results from EuroHeart Failure Survey II. Eur J Heart Fail 10:140–148. doi:10.1016/j.ejheart.2007.12.012

    Article  PubMed  Google Scholar 

  150. Cui X, Kaspar M, Zhu H, Stork S, Ertl G, Zhou J, Ge J, Angermann CE (2014) Clinical characteristics, treatment and survival in patients with systolic heart failure—comparative assessment of a Chinese and a German cohort. Int J Cardiol 176:1388–1390. doi:10.1016/j.ijcard.2014.08.026

    Article  PubMed  Google Scholar 

  151. Adams KF Jr, Sueta CA, Gheorghiade M, O’Connor CM, Schwartz TA, Koch GG, Uretsky B, Swedberg K, McKenna W, Soler-Soler J, Califf RM (1999) Gender differences in survival in advanced heart failure. Insights from the FIRST study. Circulation 99:1816–1821

    Article  Google Scholar 

  152. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73:62–68. doi:10.1136/annrheumdis-2013-204223

    Article  PubMed  Google Scholar 

  153. Moltó A, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgoçmen S, van Gaalen F, Dougados M (2016) Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study. Ann Rheum Dis 75:1016–1023. doi:10.1136/annrheumdis-2015-208174

    Article  CAS  PubMed  Google Scholar 

  154. Mentz RJ, Kelly JP, von Lueder TG, Voors AA, Lam CS, Cowie MR, Kjeldsen K, Jankowska EA, Atar D, Butler J, Fiuzat M, Zannad F, Pitt B, O'Connor CM (2014) Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction. J Am Coll Cardiol 64:2281–2293. doi:10.1016/j.jacc.2014.08.036

    Article  PubMed  PubMed Central  Google Scholar 

  155. Cheng RK, CoxM NML, Heidenreich PA, Bhatt DL, Eapen ZJ, Hernandez AF, Butler J, Yancy CW, Fonarow GC (2014) Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population. Am Heart J 168:721–730. doi:10.1016/j.ahj.2014.07.008

    Article  PubMed  Google Scholar 

  156. Martín-Martínez MA, González-Juanatey C, Castañeda S, Llorca J, Ferraz-Amaro I, Fernández-Gutiérrez B, Díaz-González F, González-Gay MA (2014) Recommendations for the management of cardiovascular risk in patients with rheumatoid arthritis: scientific evidence and expert opinion. Semin Arthritis Rheum 44:1–8. doi:10.1016/j.semarthrit.2014.01.002

    Article  PubMed  Google Scholar 

  157. Loza E, Lajas C, Andreu JL, Balsa A, González-Álvaro I, Illera O, Jover JÁ, Mateo I, Orte J, Rivera J, Rodríguez Heredia JM, Romero F, Martínez-López JA, Ortiz AM, Toledano E, Villaverde V, Carmona L, Castañeda S (2015) Consensus statement on a framework for the management of comorbidity and extra-articular manifestations in rheumatoid arthritis. Rheumatol Int 35:445–458. doi:10.1007/s00296-014-3196-7

    Article  PubMed  Google Scholar 

  158. Torre-Alonso JC, Carmona L, Moreno M, Galíndez E, Babío J, Zarco P, Linares L, Collantes-Estevez E, Barrial MF, Hermosa JC, Coto P, Suárez C, Almodóvar R, Luelmo J, Castañeda S, Gratacós J (2017) Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain. Rheumatol Int. doi:10.1007/s00296-017-3702-9

  159. González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L (2017) Recommendations for the management of comorbidity in patients with axial spondyloarthritis in clinical practice. Reumatol Clin S1699-258X(17):30081–30085. doi:10.1016/j.Reuma.2017.03.011 [Epub ahead of print] English, Spanish

    Article  Google Scholar 

  160. Gonzalez-Gay MA, Gonzalez-Juanatey C, Vazquez-Rodriguez TR, Martin J, Llorca J (2008) Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis. Semin Arthritis Rheum 38:67–70. doi:10.1016/j.semarthrit.2008.02.001

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Prof. González-Gay’s research was supported by “Fondo de Investigación Sanitaria” (grants PI06/0024, PS09/00748, PI12/00060, and PI15/00525) from “Instituto de Salud Carlos III” (ISCIII, Health Ministry, Spain). It was also partially supported by RETICS Programs RD12/0009 and RD16/0012/009 (RIER) from “Instituto de Salud Carlos III” (ISCIII, Health Ministry, Spain).

Author information

Authors and Affiliations

  1. Rheumatology Division, Hospital de La Princesa, IIS-Princesa, c/Diego de León 62, 28006, Madrid, Spain

    Santos Castañeda

  2. Universidad Autónoma de Madrid (UAM), Madrid, Spain

    Santos Castañeda

  3. Division of Cardiology, Hospital Lucus Augusti, c/ Dr. Ulises Romero 1, 27003, Lugo, Spain

    Carlos González-Juanatey

  4. Epidemiology, Genetics and Atherosclerosis Research Group on Systemic Inflammatory Diseases, IDIVAL, Rheumatology Division, Hospital Universitario Marqués de Valdecilla, University of Cantabria, Avda. de Valdecilla, s/n, 39008, Santander, Spain

    Miguel A. González-Gay

Authors
  1. Santos Castañeda
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carlos González-Juanatey
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Miguel A. González-Gay
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Santos Castañeda or Miguel A. González-Gay.

Ethics declarations

Conflict of Interest

The authors declare that they do not have conflict of interest in relation with this work.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Castañeda, S., González-Juanatey, C. & González-Gay, M.A. Sex and Cardiovascular Involvement in Inflammatory Joint Diseases. Clinic Rev Allerg Immunol 56, 278–292 (2019). https://doi.org/10.1007/s12016-017-8635-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12016-017-8635-2

Keywords

Search

Navigation